logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5148.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5148.produseast1
Outcomes of children born to pregnant women with drug-resistant tuberculosis treated with novel drugs in Khayelitsha, South Africa: a report of five patients | Journal Article / Case Report/Series | MSF Science Portal
Journal Article
|Case Report/Series

Outcomes of children born to pregnant women with drug-resistant tuberculosis treated with novel drugs in Khayelitsha, South Africa: a report of five patients

Mohr-Holland E, Daniels J, Furin J, Loveday M, Mudaly V, Reuter A
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
This brief report presents a series of 5 pregnant women treated for rifampicin-resistant tuberculosis with the novel drugs bedaquiline, delamanid, and linezolid as part of an optimized backbone regimen and reviews the outcomes of the children born to them. Although the case series is small, all children had excellent birth outcomes suggesting pregnant women should not be denied access to novel therapies for RR-TB.

Countries

South Africa

Subject Area

antibiotic resistancetuberculosiswomen's healthneonatal healthantimicrobial resistance

Languages

English
DOI
10.1097/INF.0000000000003069
Published Date
01 May 2021
PubMed ID
33847295
Journal
Pediatric Infectious Disease Journal
Volume | Issue | Pages
Volume 40, Issue 5, Pages e191-e192
Dimensions Badge